がんイメージングシステム市場：製品、イメージング技術、イメージングモード、適応症、エンドユーザー別-2025-2030年世界予測

がんイメージングシステム市場は、2023年に184億3,000万米ドルと評価され、2024年には201億6,000万米ドルに達すると予測され、CAGR 9.57％で成長し、2030年には349億6,000万米ドルに達すると予測されています。

がんイメージングシステム市場には、MRI、CTスキャン、PETスキャン、超音波、X線画像診断など、がんの診断、病期分類、モニタリングに不可欠なさまざまな技術が含まれます。この市場の必要性は、患者の転帰を改善し精密医療を促進するために高度な診断ツールを必要とする世界のがん罹患率の上昇に起因しています。この市場は、病院、診療所、診断ラボ、研究機関などあらゆる場所で応用されており、主に腫瘍医、放射線科医、医療専門家が治療計画を立てるために使用しています。成長に拍車をかけているのは、診断精度と効率を加速する画像解析強化のためのAI統合など、画像技術の進歩です。最新の潜在的なビジネスチャンスは、医療インフラがまだ発展途上の新興経済諸国に対応するポータブル画像診断機器や個別化アプリケーションの開発にあります。一方、規制の枠組み、画像処理システムの高コスト、放射線被曝の懸念が大きな課題となっています。しかし、放射線リスクを最小限に抑え、費用対効果を高める研究に投資することで、これらの問題を軽減することができます。同市場は、がん治療に対する政府のヘルスケア構想や資金援助、ハイテク企業とヘルスケアプロバイダーとの戦略的提携、効率的なヘルスケアソリューションに対する消費者の嗜好の高まりなどから大きな影響を受けています。革新的な戦略には、より優れた画像処理のためのソフトウェアの強化、予測分析のための機械学習の活用、地方向けに手頃な価格の画像診断機器の開発などがあります。市場が技術進歩で活気づく中、継続的な研究開発と戦略的提携が競争優位性をもたらします。新興市場で満たされていないニーズを特定し、患者中心の画像ソリューションに注力することで、大きな成長機会がもたらされる可能性があります。本質的に、がん画像診断システム市場はダイナミックであり、特に最先端技術の戦略的統合や新興国市場の拡大を通じて、イノベーションの機会がその限界に打ち勝つことができます。

市場力学：急速に進化するがんイメージングシステム市場の主要市場インサイトを公開

がんイメージングシステム市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の老人人口の増加
  • 世界のがん有病率の上昇
  • がん治療に対する政府の支援策
• 市場抑制要因
  • がん画像診断システムの高コスト
• 市場機会
  • 先進イメージング技術の統合に向けた継続的な共同活動
  • 先端イメージング技術の研究開発活動への投資の増加
• 市場の課題
  • 画像データの管理と相互運用性の問題

ポーターの5つの力：がんイメージングシステム市場をナビゲートする戦略ツール

ポーターの5つの力」フレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：がんイメージングシステム市場における外部からの影響の把握

外部マクロ環境要因は、がんイメージングシステム市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析がんイメージングシステム市場における競合情勢の把握

がんイメージングシステム市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスがんイメージングシステム市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、がんイメージングシステム市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨がんイメージングシステム市場における成功への道筋を描く

がんイメージングシステム市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界的に高齢化が進む
    • 世界的にがんの罹患率が上昇
    • がん治療に対する政府の支援策
  • 抑制要因
    • がん画像診断システムの高コスト
  • 機会
    • 先進的な画像技術を統合するための継続的な共同活動
    • 先進的な画像技術の研究開発活動への投資増加
  • 課題
    • 画像データの管理と相互運用性の問題
• 市場セグメンテーション分析
  • 製品：複雑な画像ニーズに対応するために病院での画像システムの使用が急増
  • エンドユーザー：がん調査機関における高度な画像診断システムの需要の高まり
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 がんイメージングシステム市場：製品別

• 消耗品とアクセサリー
• イメージングシステム
  • ポータブルイメージングデバイス
  • スタンドアロン画像撮影装置
• ソフトウェア
  • 画像解析ソフトウェア
  • 放射線情報システム

第7章 がんイメージングシステム市場イメージングテクノロジー

• コンピュータ断層撮影
• 磁気共鳴画像
• 分子イメージング
• 光学イメージング
• 陽電子放出断層撮影
• 超音波画像診断
• X線画像

第8章 がんイメージングシステム市場撮影モード別

• 2Dイメージング
• 3Dイメージング
• 4Dイメージング

第9章 がんイメージングシステム市場適応症別

• 脳腫瘍
• 乳がん
• 子宮頸がん
• 大腸がん
• 肝臓がん
• 肺がん
• 前立腺がん

第10章 がんイメージングシステム市場：エンドユーザー別

• 外来手術センター
• がん調査機関
• 画像診断センター
• 病院

第11章 南北アメリカのがんイメージングシステム市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域のがんイメージングシステム市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカのがんイメージングシステム市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • GEヘルスケア、 ESTRO 2024会議でAI強化の個別化腫瘍学ソリューションを発表
  • GEヘルスケアのMIMソフトウェアは、エレクタと提携して放射線治療を強化し、患者の転帰を改善します。
  • GEヘルスケア、 MIMソフトウェアの買収によりがん画像診断能力を拡張
• 戦略分析と提言

企業一覧

• Agfa-Gevaert N.V.
• Bruker Corporation
• Canon Medical Systems Corporation
• Carestream Health
• Curium
• Elekta AB
• Esaote S.p.A.
• Fujifilm Holdings Corporation
• GE Healthcare
• Hitachi Ltd.
• Hologic, Inc.
• iCAD, Inc.
• Imaging Endpoints
• Koning Corporation
• Medtronic PLC
• PerkinElmer, Inc.
• Philips Healthcare
• Planmed Oy
• RadNet, Inc.
• Samsung Medison
• Siemens Healthineers
• Spectrum Dynamics Medical
• Thermo Fisher Scientific Inc.
• United Imaging Healthcare Co., Ltd.
• Varian Medical Systems
• ViewRay, Inc.
• Ziehm Imaging GmbH

LIST OF FIGURES

• FIGURE 1. CANCER IMAGING SYSTEM MARKET RESEARCH PROCESS
• FIGURE 2. CANCER IMAGING SYSTEM MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. CANCER IMAGING SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. CANCER IMAGING SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CANCER IMAGING SYSTEM MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CANCER IMAGING SYSTEM MARKET DYNAMICS
• TABLE 7. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CONSUMABLES & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PORTABLE IMAGING DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY STAND-ALONE IMAGING EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY RADIOLOGY INFORMATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MOLECULAR IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY X-RAY IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY 2D IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY 3D IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY 4D IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY BRAIN CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY LIVER CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CANCER RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 48. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 52. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 53. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 54. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 55. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 56. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 59. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 60. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 61. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 62. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 63. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 66. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 67. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 68. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 69. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 70. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 73. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 74. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 76. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 77. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 80. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 81. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 82. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 83. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 84. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 86. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 88. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 89. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 90. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 91. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 92. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 94. AUSTRALIA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. AUSTRALIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 96. AUSTRALIA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 97. AUSTRALIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 98. AUSTRALIA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 99. AUSTRALIA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 100. AUSTRALIA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. CHINA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. CHINA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 103. CHINA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 104. CHINA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 105. CHINA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 106. CHINA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 107. CHINA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. INDIA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. INDIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 110. INDIA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 111. INDIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 112. INDIA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 113. INDIA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 114. INDIA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. INDONESIA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. INDONESIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 117. INDONESIA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 118. INDONESIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 119. INDONESIA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 120. INDONESIA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 121. INDONESIA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. JAPAN CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. JAPAN CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 124. JAPAN CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 125. JAPAN CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 126. JAPAN CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 127. JAPAN CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 128. JAPAN CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. MALAYSIA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. MALAYSIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 131. MALAYSIA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 132. MALAYSIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 133. MALAYSIA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 134. MALAYSIA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 135. MALAYSIA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. PHILIPPINES CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. PHILIPPINES CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 138. PHILIPPINES CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 139. PHILIPPINES CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 140. PHILIPPINES CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 141. PHILIPPINES CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 142. PHILIPPINES CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. SINGAPORE CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. SINGAPORE CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 145. SINGAPORE CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 146. SINGAPORE CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 147. SINGAPORE CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 148. SINGAPORE CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 149. SINGAPORE CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. SOUTH KOREA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 151. SOUTH KOREA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 152. SOUTH KOREA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 153. SOUTH KOREA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 154. SOUTH KOREA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 155. SOUTH KOREA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 156. SOUTH KOREA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 157. TAIWAN CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. TAIWAN CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 159. TAIWAN CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 160. TAIWAN CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 161. TAIWAN CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 162. TAIWAN CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 163. TAIWAN CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 164. THAILAND CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 165. THAILAND CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 166. THAILAND CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 167. THAILAND CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 168. THAILAND CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 169. THAILAND CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 170. THAILAND CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. VIETNAM CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 172. VIETNAM CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 173. VIETNAM CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 174. VIETNAM CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 175. VIETNAM CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 176. VIETNAM CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 177. VIETNAM CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 178. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 179. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 180. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 181. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 182. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 183. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 184. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 186. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 187. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 188. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 189. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 190. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 191. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 192. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 193. EGYPT CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 194. EGYPT CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 195. EGYPT CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 196. EGYPT CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 197. EGYPT CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 198. EGYPT CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 199. EGYPT CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 200. FINLAND CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 201. FINLAND CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 202. FINLAND CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 203. FINLAND CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 204. FINLAND CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 205. FINLAND CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 206. FINLAND CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 207. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 208. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 209. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 210. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 211. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 212. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 213. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 214. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 215. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 216. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 217. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 218. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 219. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 220. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 221. ISRAEL CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 222. ISRAEL CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 223. ISRAEL CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 224. ISRAEL CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 225. ISRAEL CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 226. ISRAEL CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 227. ISRAEL CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 228. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 229. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 230. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 231. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 232. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 233. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 234. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 235. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 236. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 237. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 238. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 239. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 240. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 241. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 242. NIGERIA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 243. NIGERIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 244. NIGERIA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 245. NIGERIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 246. NIGERIA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 247. NIGERIA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 248. NIGERIA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 249. NORWAY CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 250. NORWAY CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 251. NORWAY CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 252. NORWAY CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 253. NORWAY CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 254. NORWAY CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 255. NORWAY CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 256. POLAND CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 257. POLAND CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 258. POLAND CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 259. POLAND CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 260. POLAND CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 261. POLAND CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 262. POLAND CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 263. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 264. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 265. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 266. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 267. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 268. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 269. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 270. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 271. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 272. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 273. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 274. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 275. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 276. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 277. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 278. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 279. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 280. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 281. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 282. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 283. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 284. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 285. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 286. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 287. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 288. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 289. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 290. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 291. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 292. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 293. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 294. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 295. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 296. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 297. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 298. SWEDEN CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 299. SWEDEN CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 300. SWEDEN CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 301. SWEDEN CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 302. SWEDEN CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 303. SWEDEN CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 304. SWEDEN CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 305. SWITZERLAND CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 306. SWITZERLAND CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 307. SWITZERLAND CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 308. SWITZERLAND CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 309. SWITZERLAND CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 310. SWITZERLAND CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 311. SWITZERLAND CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 312. TURKEY CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 313. TURKEY CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 314. TURKEY CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 315. TURKEY CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 316. TURKEY CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 317. TURKEY CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 318. TURKEY CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 319. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 320. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 321. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 322. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 323. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 324. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 325. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 326. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 327. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 328. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 329. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 330. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
• TABLE 331. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 332. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 333. CANCER IMAGING SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 334. CANCER IMAGING SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

The Cancer Imaging System Market was valued at USD 18.43 billion in 2023, expected to reach USD 20.16 billion in 2024, and is projected to grow at a CAGR of 9.57%, to USD 34.96 billion by 2030.

The cancer imaging system market covers a range of technologies, including MRI, CT scans, PET scans, ultrasound, and X-ray imaging, each essential in diagnosing, staging, and monitoring cancer. This market's necessity stems from the rising global cancer incidence that demands advanced diagnostic tools to improve patient outcomes and facilitate precision medicine. It finds application across hospitals, clinics, diagnostic labs, and research institutions, primarily used by oncologists, radiologists, and medical professionals to guide treatment plans. Growth is spurred by advancements in imaging technology, such as AI integration for enhanced image analysis, which accelerates diagnostic accuracy and efficiency. Latest potential opportunities lie in developing portable imaging devices and personalized applications that cater to emerging economies where healthcare infrastructure is still developing. Meanwhile, regulatory frameworks, high costs of imaging systems, and radiation exposure concerns pose significant challenges. However, investing in research that minimizes radiation risks and enhances cost-effectiveness can mitigate these issues. The market is considerably influenced by governmental healthcare initiatives and funding towards cancer treatment, strategic collaborations between tech companies and healthcare providers, and an increasing consumer preference for efficient healthcare solutions. Innovative strategies include enhancing software for better image processing, utilizing machine learning for predictive analytics, and creating more affordable imaging equipment for rural areas. As the market thrives on technological progression, continuous R&D and strategic alliances can offer competitive advantages. Identifying unmet needs in emerging markets and focusing on patient-centric imaging solutions can provide substantial growth opportunities. In essence, the cancer imaging systems market is dynamic, with opportunities for innovation overshadowing its limitations, particularly through the strategic integration of cutting-edge technologies and expanding reach across developing regions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cancer Imaging System Market

The Cancer Imaging System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing geriatric population globally
  • Rising prevalence of cancer globally
  • Supportive government initiatives for cancer treatments
• Market Restraints
  • High costs of cancer imaging systems
• Market Opportunities
  • Ongoing collaborative activities for integrating advanced imaging technologies
  • Rising investments in R&D activities for advanced imaging technologies
• Market Challenges
  • Data management and interoperability issues of imaging data

Porter's Five Forces: A Strategic Tool for Navigating the Cancer Imaging System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cancer Imaging System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cancer Imaging System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cancer Imaging System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cancer Imaging System Market

A detailed market share analysis in the Cancer Imaging System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cancer Imaging System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cancer Imaging System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cancer Imaging System Market

A strategic analysis of the Cancer Imaging System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cancer Imaging System Market, highlighting leading vendors and their innovative profiles. These include Agfa-Gevaert N.V., Bruker Corporation, Canon Medical Systems Corporation, Carestream Health, Curium, Elekta AB, Esaote S.p.A., Fujifilm Holdings Corporation, GE Healthcare, Hitachi Ltd., Hologic, Inc., iCAD, Inc., Imaging Endpoints, Koning Corporation, Medtronic PLC, PerkinElmer, Inc., Philips Healthcare, Planmed Oy, RadNet, Inc., Samsung Medison, Siemens Healthineers, Spectrum Dynamics Medical, Thermo Fisher Scientific Inc., United Imaging Healthcare Co., Ltd., Varian Medical Systems, ViewRay, Inc., and Ziehm Imaging GmbH.

Market Segmentation & Coverage

This research report categorizes the Cancer Imaging System Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Consumables & Accessories, Imaging Systems, and Software. The Imaging Systems is further studied across Portable Imaging Devices and Stand-alone Imaging Equipment. The Software is further studied across Imaging Analysis Software and Radiology Information Systems.
• Based on Imaging Technology, market is studied across Computed Tomography, Magnetic Resonance Imaging, Molecular Imaging, Optical Imaging, Positron Emission Tomography, Ultrasound Imaging, and X-Ray Imaging.
• Based on Mode of Imaging, market is studied across 2D Imaging, 3D Imaging, and 4D Imaging.
• Based on Indication, market is studied across Brain Cancer, Breast Cancer, Cervical Cancer, Colorectal Cancer, Liver Cancer, Lung Cancer, and Prostate Cancer.
• Based on End-User, market is studied across Ambulatory Surgical Centers, Cancer Research Institutes, Diagnostic Imaging Centers, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing geriatric population globally
    • 5.1.1.2. Rising prevalence of cancer globally
    • 5.1.1.3. Supportive government initiatives for cancer treatments
  • 5.1.2. Restraints
    • 5.1.2.1. High costs of cancer imaging systems
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing collaborative activities for integrating advanced imaging technologies
    • 5.1.3.2. Rising investments in R&D activities for advanced imaging technologies
  • 5.1.4. Challenges
    • 5.1.4.1. Data management and interoperability issues of imaging data
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product : Proliferating use of imaging systems in hospitals for intricate imaging needs
  • 5.2.2. End-User : Rising demand for advanced imaging systems cancer research institutes
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cancer Imaging System Market, by Product

• 6.1. Introduction
• 6.2. Consumables & Accessories
• 6.3. Imaging Systems
  • 6.3.1. Portable Imaging Devices
  • 6.3.2. Stand-alone Imaging Equipment
• 6.4. Software
  • 6.4.1. Imaging Analysis Software
  • 6.4.2. Radiology Information Systems

7. Cancer Imaging System Market, by Imaging Technology

• 7.1. Introduction
• 7.2. Computed Tomography
• 7.3. Magnetic Resonance Imaging
• 7.4. Molecular Imaging
• 7.5. Optical Imaging
• 7.6. Positron Emission Tomography
• 7.7. Ultrasound Imaging
• 7.8. X-Ray Imaging

8. Cancer Imaging System Market, by Mode of Imaging

• 8.1. Introduction
• 8.2. 2D Imaging
• 8.3. 3D Imaging
• 8.4. 4D Imaging

9. Cancer Imaging System Market, by Indication

• 9.1. Introduction
• 9.2. Brain Cancer
• 9.3. Breast Cancer
• 9.4. Cervical Cancer
• 9.5. Colorectal Cancer
• 9.6. Liver Cancer
• 9.7. Lung Cancer
• 9.8. Prostate Cancer

10. Cancer Imaging System Market, by End-User

• 10.1. Introduction
• 10.2. Ambulatory Surgical Centers
• 10.3. Cancer Research Institutes
• 10.4. Diagnostic Imaging Centers
• 10.5. Hospitals

11. Americas Cancer Imaging System Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Cancer Imaging System Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Cancer Imaging System Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. GE Healthcare unveils AI-enhanced personalized oncology solutions at ESTRO 2024 Congress
  • 14.3.2. GE Healthcare's MIM Software collaborates with Elekta to help enhance radiation therapy treatments and improve patient outcomes
  • 14.3.3. GE Healthcare expands cancer imaging capabilities with acquisition of MIM Software
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agfa-Gevaert N.V.
• 2. Bruker Corporation
• 3. Canon Medical Systems Corporation
• 4. Carestream Health
• 5. Curium
• 6. Elekta AB
• 7. Esaote S.p.A.
• 8. Fujifilm Holdings Corporation
• 9. GE Healthcare
• 10. Hitachi Ltd.
• 11. Hologic, Inc.
• 12. iCAD, Inc.
• 13. Imaging Endpoints
• 14. Koning Corporation
• 15. Medtronic PLC
• 16. PerkinElmer, Inc.
• 17. Philips Healthcare
• 18. Planmed Oy
• 19. RadNet, Inc.
• 20. Samsung Medison
• 21. Siemens Healthineers
• 22. Spectrum Dynamics Medical
• 23. Thermo Fisher Scientific Inc.
• 24. United Imaging Healthcare Co., Ltd.
• 25. Varian Medical Systems
• 26. ViewRay, Inc.
• 27. Ziehm Imaging GmbH